AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2022 Issue 4; New/Revised ICD-10-PCS Codes Section 3 - Administration
Introduction of Other Therapeutic Monoclonal Antibody
In the Administration Section, table 3E0, Introduction of Physiological Systems and Anatomical Regions, the qualifier value R Other Therapeutic Monoclonal Antibody, was added to body system/region values 3 Peripheral Vein and 4 Central Vein. This change will identify the administration of monoclonal antibodies such as bezlotoxumab (ZINPLAVA™), when used for non-neoplastic and non-COVID related indications.Body System/ Region Approach Substance Qualifier 3 Peripheral Vein 4 Central Vein 3 Percutaneous G Other Therapeutic Substance R Other Therapeutic Monoclonal Antibody In Section X, New Technology, table XW0, Introduction of Anatomical Regions, the following codes that uniquely identified the introduction of...
Subscribe or sign in to view the full article.
Article Overview
This article covers an ICD-10-PCS update in the Administration section and a related change in the New Technology section. It is relevant to coding professionals, CDI staff, and compliance teams who track official code set revisions for infusion and administration procedures. The article summarizes how the update affects body system/region values and notes the deletion of specific New Technology codes tied to a monoclonal antibody product.
Why This Topic Matters
Understanding these ICD-10-PCS changes helps facilities keep procedure coding aligned with current official tables and avoid reliance on deleted New Technology entries. It is especially important for organizations coding medication administrations and maintaining code set updates.
Article Sections
-
Administration Section
Covers an update to the ICD-10-PCS Administration table affecting body system and region values for venous access. The section focuses on a change intended to distinguish a category of therapeutic monoclonal antibody administration.
-
Section X, New Technology
Describes deletions from the ICD-10-PCS New Technology table related to a monoclonal antibody product. The section addresses the removal of entries that previously identified this type of introduction procedure.
What You Will Learn
- Which ICD-10-PCS section was updated
- How the Administration table was revised at a high level
- Which New Technology table entries were removed
- Why the update is relevant to monoclonal antibody administration coding
Who Should Read This
- Medical coders
- Coding auditors
- Clinical documentation integrity specialists
- Revenue cycle teams
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com